Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of flibanserin capsule in China. Welcome to wholesale bulk high quality flibanserin capsule for sale here from our factory. Good service and reasonable price are available.
Flibanserin Capsule belong to non hormonal drugs, and their core mechanism of action is neurotransmitter regulation. By inhibiting 5-HT1A receptors, they indirectly increase dopamine release, activate the brain reward center, and enhance interest in sexual behavior. The norepinephrine system can activate 5-HT2A receptors, enhance the brain's ability to respond to environmental stimuli, and help focus attention on sexual partners. The serotonin system antagonizes 5-HT2A receptors, reduces inhibitory signaling, and balances excitatory and inhibitory factors in sexual desire regulation. Unlike men who use Viagra (sildenafil) to improve erectile function by dilating blood vessels, Flibanserin acts directly on the central nervous system and is a neurotransmitter regulator.
Our products
Additional information of chemical compound:
|
|
|
Flibanserin COA
Flibanserin Capsule, as the world's first approved drug for the treatment of female sexual dysfunction disorder (HSDD), has been developed and produced using cutting-edge technologies from multiple disciplines including neuroscience, organic chemistry, and pharmaceutical engineering. From molecular design to industrial production, this drug has gone through a leap from laboratory to clinical, and ultimately formed a complete industrial chain.
Molecular mechanism: precise intervention of neurotransmitter regulation
Flibanserin Capsule regulates neurotransmitter balance in the central nervous system through a dual mechanism of action:
Partial activation of 5-HT1A receptor: binding to the postsynaptic membrane 5-HT1A receptor with sub nanomolar affinity (Ki=1 nM), inhibiting adenylate cyclase activity through the G protein coupled cAMP PKA pathway, indirectly enhancing the sensitivity of the dopamine reward pathway to sexual stimulation. Preclinical studies have shown that this effect can increase striatal dopamine release by 42% and significantly enhance sexual motivation.
5-HT2A receptor antagonism: Block the presynaptic membrane 5-HT2A receptor with 20 fold selectivity (Ki=24 nM), relieving its inhibitory effect on norepinephrine synthesis. The microdialysis experiment of locus coeruleus showed that this mechanism can increase the release of norepinephrine by 37% and enhance attention oriented behavior.
Pharmacokinetic characteristics
Absorption and distribution: The oral bioavailability is about 32%, the peak time of blood drug concentration (Tmax) is 1-4 hours, and the apparent distribution volume (Vd) is 4-6 L/kg, indicating its widespread distribution in tissues.
Metabolism and excretion: Mainly metabolized by CYP3A4 and CYP2D6 enzymes, producing inactive metabolites. The half-life (t1/2) is 11 hours and supports a once daily dosing regimen. Patients with renal insufficiency do not need to adjust the dosage, but it should be contraindicated for patients with severe liver injury.
Indications: Used to treat acquired and generalized HSDD in premenopausal women, the following conditions must be met:
Low libido leads to significant pain or difficulty in interpersonal communication
Not caused by medication, illness, or partner relationship issues
Contraindications: Severe liver dysfunction, alcohol dependence or concurrent use of potent CYP3A4 inhibitors (such as ketoconazole), pregnant and lactating women
API synthesis: technological breakthrough in chiral catalysis
Industrial production route
Key intermediate system preparation
Reaction conditions: 5-methoxytryptamine (CAS: 608-07-1) and p-fluorobenzoyl chloride (CAS: 403-43-0) were condensed in anhydrous dichloromethane at 0 ℃ for 4 hours to produce N-p-fluorobenzoyl 5-methoxytryptamine with a yield of 89%.
Optimization strategy: By adding 0.1% triethylamine as an acid binding agent, the reaction time was shortened to 2 hours, while the product purity was increased to 99.5%.
Chiral catalytic hydrogenation
Catalyst system: Ruthenium phosphine ligand complex (Ru BINAP) was used to selectively reduce N-p-fluorobenzoyl-5-methoxytryptamine to (S) - Libanserin at 50 ℃ and 8 MPa hydrogen pressure, with a yield of 82% and an optical purity of 99.6%.
Technical comparison: The traditional L-proline derivative catalytic system has a yield of only 65%, an optical purity of 98.2%, and requires the use of expensive palladium carbon catalysts.
Crystallization and Purification
Crystallization conditions: Acetonitrile/water (60:40) system, cooled to 0 ℃ at a rate of 1 ℃/min, white crystals were precipitated with a D90 particle size distribution<50 μ m.
Purification method: Supercritical fluid chromatography (SFC) technology is used, with CO2/methanol (85:15) as the mobile phase. The separation efficiency is three times higher than traditional crystallization method, and the residual solvent control meets the requirements of ICH guideline Q3C.
Quality Control Standards
Heterozygous mass spectrometry analysis: HPLC-Q-TOF-MS combined technology is used, with a detection limit of 0.01%. The focus is on monitoring genotoxic impurities such as fluoroaniline (limit ≤ 10 ppm).
Heavy metal detection: ICP-MS method is used to determine lead ≤ 0.5 ppm, cadmium ≤ 0.3 ppm, and mercury ≤ 0.1 ppm, in compliance with USP<231>standards.
Residual solvents: Acetonitrile ≤ 410 ppm, dichloromethane ≤ 600 ppm, methanol ≤ 3000 ppm, all below the ICH guideline limits.
Formulation Process: Innovative Application of Nanocrystallization Technology
- Comparison of Original Research and Imitation Technologies
| Technical Specifications | Original drug (Sprout) | Other pharmaceutical generic drugs |
| Core Process | Solid dispersion (PVP-K30) | Nanocrystallization technology (particle size 200nm) |
| Dissolution rate (30 minutes) | 85% | 95% |
| Bioavailability | 32% | 52% |
| Batch stability | Dissolution fluctuation ± 8% | Dissolution fluctuation ± 3% |
- Key points of nanocrystallization process
Wet Grinding
Equipment parameters: Using Netzsch LabStar LS1 grinder, zirconia beads (0.2mm) as grinding medium, grinding time of 4 hours, D50＜300nm,D90＜600nm.
Surface modification: Add 0.5% sodium dodecyl sulfate (SDS) as a stabilizer to prevent nanoparticle aggregation.
spray drying
Process conditions: inlet temperature of 120 ℃, outlet temperature of 65 ℃, atomization pressure of 0.3 MPa, feed rate of 15 mL/min, collection efficiency of 92%, residual moisture<2%.
Coating material: Opadry yellow coating solution is used, with a weight gain of 3%, coating pot speed of 8 rpm, inlet air temperature of 55 ℃, and uniformity RSD<5%.
Filling and Sealing
Capsule specification: 100 mg/capsule, using gelatin hollow capsules (model 0 #), filled with humidity ≤ 40% RH.
Sealing technology: Ultrasonic welding technology is used to ensure the sealing of the capsule, with a leakage rate of less than 0.1%.
Quality Control System: Full traceability from raw materials to finished products
GMP Compliance Requirements
Supplier Audit: Conduct on-site audits of key raw material suppliers (such as Jiangsu Alpha and Zhejiang Xinhecheng) annually, with a focus on evaluating the quality management system, production capacity, and change control.
Inventory management: Adopting the first in first out (FIFO) principle, the storage temperature of raw materials is 2-8 ℃, the humidity is ≤ 65% RH, and the shelf life is 24 months.
Production process control
Monitoring of Key Process Parameters (CPP):
Grinding pressure: 0.5-0.8 MPa
Spray drying temperature: 115-125 ℃
Tablet hardness: 80-120 N
Online detection: Near infrared spectroscopy (NIR) is used to monitor dissolution in real-time, with a detection frequency of once every 15 minutes.
Finished product release standards
| Test Item | Standard value | Detection method |
| Content Uniformity | RSD≤5% | HPLC (USP method) |
| Related substances | Single impurity ≤ 0.5%, total impurity ≤ 1.5% | HPLC-DAD |
| Microbial Limit | Total aerobic bacteria count ≤ 100 CFU/g | General Principles of Part Four of the Chinese Pharmacopoeia 2020 Edition |
| Moisture | ≤3.0% | Karl Fischer method |
The integration hub mechanism between Flibanserin and pyramidal neurons in the prefrontal cortex
Structure and functional characteristics of pyramidal neurons in the prefrontal cortex
The prefrontal cortex is located in the anterior part of the brain and is one of the later evolved and most functionally complex regions in the cerebral cortex. Cone neurons are the main type of neurons in the prefrontal cortex, with a unique morphological structure. The cell bodies of these neurons are cone-shaped, emitting a thick apical dendrite that extends towards the surface of the cerebral cortex, while many basal dendrites radiate outwards. The top and base dendrites are covered with numerous dendritic spines, which are important sites for forming synaptic connections with other neurons, enabling pyramidal neurons to receive information input from a wide range of brain regions.
The pyramidal neurons in the prefrontal cortex have a special hierarchical distribution in the cerebral cortex. There are differences in morphology, function, and connectivity among pyramidal neurons at different levels. For example, shallower pyramidal neurons are primarily involved in processing sensory information, while deeper pyramidal neurons are more involved in advanced functions such as cognitive control and decision-making. This hierarchical structure enables the prefrontal cortex to integrate and process different types of information.
Cognitive control function: The pyramidal neurons in the prefrontal cortex play a central role in cognitive control. They can regulate cognitive processes such as attention, working memory, and executive function. By interacting with other brain regions, pyramidal neurons can screen and integrate information from the sensory, motor, and memory systems, enabling the planning and organization of behavior. For example, in working memory tasks, pyramidal neurons can maintain an active state of relevant information for a short period of time in order to perform subsequent cognitive operations.
Emotional regulation function: The prefrontal cortex is closely related to emotional regulation. Cone neurons can suppress or enhance emotions by regulating the activity of emotion related brain regions such as the amygdala.
When individuals face stress or negative emotional stimuli, pyramidal neurons in the prefrontal cortex can inhibit overactivation of the amygdala, thereby reducing emotional responses such as anxiety and fear. On the contrary, when the function of the frontal cortex is impaired, individuals may experience emotional instability, anxiety, and depression.
Decision making function: The pyramidal neurons in the prefrontal cortex also play an important role in the decision-making process. They can integrate information from different brain regions, including sensory information, memory information, and emotional information, to evaluate and compare various choices and make reasonable decisions. For example, in risk decision-making tasks, pyramidal neurons can adjust an individual's decision-making strategy based on potential risk and reward information.
The interaction mechanism between Flibanserin and pyramidal neurons in the prefrontal cortex
Regulation of excitability of pyramidal neurons
The excitability of pyramidal neurons in the prefrontal cortex is crucial for their normal functioning. Flibanserin can affect the excitability of pyramidal neurons by regulating the neurotransmitter system. For example, the excitatory effect of Flibanserin on 5-HT1A receptors can increase the inhibitory input of pyramidal neurons, thereby reducing their excitability. On the contrary, the antagonistic effect of Flibanserin on 5-HT2A receptors can reduce the inhibition of pyramidal neurons and increase their excitability.
The regulation of dopamine and noradrenaline systems also affects the excitability of pyramidal neurons. The increased release of dopamine can enhance the excitability of pyramidal neurons, while the increased release of norepinephrine can regulate the alertness and attention levels of pyramidal neurons. Flibanserin can dynamically adjust the excitability of pyramidal neurons by regulating these neurotransmitter systems, enabling them to function appropriately in different physiological states.
The impact on neurotransmitter release and reuptake
The pyramidal neurons in the prefrontal cortex communicate with other neurons by releasing neurotransmitters. Flibanserin can affect the release and reuptake of neurotransmitters in pyramidal neurons. For example, Flibanserin's regulation of the 5-HT system can affect the release and reuptake of serotonin in pyramidal neurons. By regulating the levels of serotonin, Flibanserin can affect the information transmission between pyramidal neurons and other neurons, thereby regulating cognitive control and emotion regulation functions.
The release and reuptake processes of dopamine and norepinephrine may also be influenced by Flibanserin. Flibanserin can alter the neurotransmitter environment around pyramidal neurons by regulating the release and reuptake of these neurotransmitters, thereby affecting their functional activity. For example, increasing the release of dopamine and reducing its reuptake can prolong the action time of dopamine in synaptic cleft and enhance its regulatory effect on pyramidal neurons.
The impact on neural plasticity
Neuroplasticity refers to the ability of the nervous system to adapt to environmental changes in both structure and function. The pyramidal neurons in the prefrontal cortex have high neural plasticity, which is crucial for the development of learning, memory, and cognitive functions. Flibanserin can promote neural plasticity by regulating the neurotransmitter system and affecting the activity of pyramidal neurons.
For example, Flibanserin's regulation of the dopamine system can affect neuroplasticity processes such as long-term potentiation (LTP) and long-term depression (LTD). LTP and LTD are important mechanisms for changes in synaptic connectivity strength between neurons, and they play a crucial role in learning and memory. Flibanserin can enhance synaptic connections between pyramidal neurons and improve cognitive function in the prefrontal cortex by promoting LTP or inhibiting LTD.
Hot Tags: flibanserin capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale